台股 » 明基醫 » 個股財報 » 杜邦分析

明基醫

(4116)
可現股當沖
  • 股價
    48.00
  • 漲跌
    ▼0.50
  • 漲幅
    -1.03%
  • 成交量
    34
  • 產業
    上櫃 生技醫療類股 ▼0.86%
  • 本地時間:13:30

    92人加入追蹤

    立即追蹤

明基醫 (4116) 財務報表-杜邦分析
杜邦分析

稅後淨利率 = 稅後淨利÷營業收入。

總資產週轉率 = (營業收入-營業成本-營業費用)÷營業收入。

權益乘數 = 稅前淨利÷營業收入。

明基醫 (4116) ROE-杜邦分析圖

Created with Highstock 1.3.7明基醫 (4116)嗨投資 histock.twROE季收盤價2020202020212021202120222022202220232023202320242024202420250%2.5%5%7.5%10%20406080
Created with Highstock 1.3.7明基醫 (4116)嗨投資 histock.tw稅後淨利率總資產週轉率季收盤價2020202020212021202120222022202220232023202320242024202420250%5%10%15%20%20406080
Created with Highstock 1.3.7明基醫 (4116)嗨投資 histock.tw權益乘數季收盤價2020202020212021202120222022202220232023202320242024202420250%1%2%3%20406080

明基醫 (4116) 歷年杜邦分析

年度/季別ROE稅後淨利率總資產週轉率權益乘數
2024Q43.09%5.32%0.26%2.29
2024Q32.83%5.06%0.25%2.20
2024Q22.90%5.19%0.25%2.20
2024Q12.07%4.21%0.23%2.20
2023Q45.70%6.22%0.42%2.16
2023Q33.97%6.49%0.29%2.18
2023Q21.82%4.11%0.22%1.94
2023Q12.10%5.19%0.20%2.03
2022Q42.25%4.96%0.23%1.96
2022Q32.93%6.47%0.23%1.97
2022Q23.08%6.30%0.25%1.97
2022Q17.23%16.03%0.24%2.01
2021Q42.04%5.30%0.23%1.78
2021Q31.32%3.76%0.22%1.63
2021Q20.49%1.58%0.19%1.63
2021Q10.66%2.22%0.19%1.58
2020Q43.68%9.84%0.23%1.61
2020Q32.20%6.35%0.21%1.61
2020Q21.02%3.42%0.19%1.64
2020Q10.85%3.14%0.18%1.52
明基醫受惠較佳產品組合 Q2毛利率站回30%Anue鉅亨-2024/08/01
佳世達旗下明基醫院遞交香港上市申請文件 財務穩健增長Anue鉅亨-2024/04/15
明基醫 相關文章
明基醫 相關影音